PUBLISHER: Grand View Research | PRODUCT CODE: 1790019
PUBLISHER: Grand View Research | PRODUCT CODE: 1790019
U.S. Clinical Trial Packaging Market Summary
The U.S. clinical trial packaging market size was estimated at USD 915.9 million in 2024 and is projected to reach USD 1,611.4 million by 2030, growing at a CAGR of 9.9% from 2025 to 2030. The growth is driven by the increasing number of clinical trials, particularly for novel drugs and therapies, including biologics and gene therapies.
The rising prevalence of chronic diseases necessitates continuous research and development in the pharmaceutical and biotechnology sectors, leading to a higher demand for specialized packaging solutions to ensure drug stability, safety, and integrity throughout the trial phases. Increasing regulatory scrutiny and the complexity of trial protocols necessitate secure and adaptive packaging formats. The growth of the U.S. clinical trial packaging industry is primarily driven by the rising number of clinical trials, spurred by growing investments in pharmaceutical R&D and the surge in novel drug development.
Innovation is a cornerstone of the U.S. clinical trial packaging industry, continuously driven by the need for enhanced drug stability, patient compliance, and supply chain efficiency. Companies invest in smart packaging technologies, such as RFID and temperature monitoring devices, to provide real-time data on product conditions and ensure integrity throughout cold chain logistics.
U.S. Clinical Trial Packaging Market Report Segmentation
This report forecasts revenue growth at U.S. level and provides an analysis of the latest industry trends in each of the sub-segments from 2018 to 2030. For this study, Grand View Research has segmented the U.S. clinical trial packaging industry report based on material, product, and end use: